U.S. News & World Report: Rong Xu, professor and director of the Center for AI in Drug Discovery, and Pamela B. Davis, the Arline H. and Curtis F. Garvin Research Professor at the School of Medicine, discussed their new study, which found that semaglutide—the active drug found in Ozempic—is linked to reduced incidence and recurrence of alcohol abuse or dependence.
